GRAND
RAPIDS, Mich., July 9, 2024
/PRNewswire/ -- Genesis Innovation Group (GIG) is pleased to
announce the appointment of Mr. Chance
Leonard as Chief Executive Officer.
Genesis Innovation Group has founded and
supported a number of significant technologies broadly recognized
in the marketplace.
Mr. Leonard brings a distinguished 29-year career in the medical
device industry to Genesis Innovation Group, with a wealth of
experience and expertise. Known for his influential, determined,
and passionate leadership, Mr. Leonard has a proven track record of
major accomplishments with high-profile orthopedic companies.
Most recently, Mr. Leonard served as Chief Commercial Officer at
Skeletal Dynamics, where he spearheaded the creation of a trusted
global brand, establishing Skeletal Dynamics as the premier upper
extremity company worldwide. Under his leadership, the company
experienced a remarkable 330% growth in the US over the past six
years through commercial execution excellence and a focused organic
portfolio development strategy.
Prior to his tenure at Skeletal Dynamics, Mr. Leonard was Vice
President of Stanmore Implants, where he successfully
commercialized the United States
platform in the competitive oncology and limb preservation market.
He and his team's efforts contributed significantly to the
acquisition of Stanmore Implants by Stryker in April 2016. Mr. Leonard has also held leadership
roles at Synthes and Zimmer, where he developed aggressive growth
strategies, a disciplined operational structure, and world-class
teams with exceptional customer focus and execution excellence.
"We are excited to announce the appointment of Chance Leonard as our new Chief Executive
Officer and are confident that Chance will lead the company to new
heights of commercial success," said Rob
Ball, Genesis Innovation Group's Chairman of the Board.
"Chance brings to Genesis over 29 years of leadership experience in
medical device commercialization. He has demonstrated a deep
understanding of market intelligence, dynamics, and a relentless
drive for excellence. His strategic insights and passion for GIG's
mission make him the ideal leader to guide the company into the
future."
"It is a privilege and honor to be given the opportunity to lead
the team at Genesis Innovation Group, and I deeply appreciate the
trust and confidence placed in me," said Mr. Leonard. "GIG has an
outstanding track record of success and has been a catalyst for
delivering important innovations to the market that positively
impact patient care. The opportunity for further impact and success
is limitless, and I look forward to contributing to the mission and
serving the team and our customers."
Genesis has enjoyed meaningful success in its short tenure as an
innovation organization. Genesis has founded and/or supported a
number of significant technologies broadly recognized in the
marketplace, including among others:
Shoulder Innovations Inc., one of the fasted growing orthopedic
companies in the space today.
HAPPE Spine, creator of the novel Hydroxyapatite Porous PEEK
device and process recently awarded Orthopedics This Week
Spine Technology of the Year Award.
Nanochon Inc, which has groundbreaking technology for the
treatment of focal cartilage defects that allows the patient's own
cartilage to regrow and fill the defect.
Sterile Processing Express (SPDx), a specialty service provider
of off-site sterilization services for joint replacement at ASC,
now currently servicing customers in the southwestern US.
Embody, recently acquired by Zimmer Biomet, delivers
arthroscopic patch augmentation for rotator cuff repair.
ProVoyance, the first FDA-cleared AI-enabled MSK application for
pre-surgical planning of joint replacement.
Magnesium Development Company (MDC), a novel, resorbable alloy
of magnesium with the strength and handling properties of
metal.
cultivate(MD), a medical device venture capital
company focused on early staged medical device investing.
Genesis seeks to continue this legacy of success and expand its
footprint in the medical device innovation space through an
enhanced leadership team and a refocused strategy centered around
innovation and partnership.
About Genesis Innovation Group
With more than 100 patents and innovations among its founders,
Genesis Innovation Group is a leader in medical device development
and commercialization. The company partners with medical device
companies and surgeon-inventors to develop new technologies that
advance human health and medicine.
Learn more about Genesis Innovation Group at:
https://genesisinnovationgroup.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/genesis-innovation-group-appoints-chance-leonard-as-chief-executive-officer-302190347.html
SOURCE Genesis Innovation Group